Total Payments
$18,042
2024 Payments
$2,212
Companies
57
Transactions
1,011
Medicare Patients
6,627
Medicare Billing
$631,830
Payment Breakdown by Category
Food & Beverage$17,885 (99.1%)
Education$157.19 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,885 | 999 | 99.1% |
| Education | $157.19 | 12 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,967 | 149 | $0 (2024) |
| Novo Nordisk Inc | $2,794 | 170 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,404 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $905.72 | 63 | $0 (2024) |
| PFIZER INC. | $854.20 | 61 | $0 (2024) |
| Merck Sharp & Dohme LLC | $785.61 | 64 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $775.38 | 76 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $750.04 | 43 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $745.04 | 35 | $0 (2024) |
| Amgen Inc. | $706.92 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,212 | 96 | AstraZeneca Pharmaceuticals LP ($666.99) |
| 2023 | $2,102 | 101 | AstraZeneca Pharmaceuticals LP ($290.06) |
| 2022 | $1,821 | 93 | Novo Nordisk Inc ($407.28) |
| 2021 | $2,302 | 120 | Novo Nordisk Inc ($618.29) |
| 2020 | $1,642 | 87 | AstraZeneca Pharmaceuticals LP ($790.22) |
| 2019 | $2,910 | 179 | AstraZeneca Pharmaceuticals LP ($900.82) |
| 2018 | $2,780 | 177 | AstraZeneca Pharmaceuticals LP ($689.37) |
| 2017 | $2,272 | 158 | AstraZeneca Pharmaceuticals LP ($349.33) |
All Payment Transactions
1,011 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.13 | General |
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Biological | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $108.63 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $122.52 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Endocrinology | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,336 | 2,120 | $301,192 | $154,111 |
| 2022 | 26 | 1,188 | 1,572 | $225,956 | $115,764 |
| 2021 | 29 | 1,811 | 2,554 | $305,783 | $167,510 |
| 2020 | 37 | 2,292 | 3,726 | $422,642 | $194,444 |
Total Patients
6,627
Total Services
9,972
Medicare Billing
$631,830
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 380 | $76,000 | $33,220 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 154 | 154 | $31,366 | $20,494 | 65.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 92 | 102 | $26,520 | $15,250 | 57.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 227 | $21,338 | $11,244 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 172 | $24,424 | $10,039 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 64 | $17,984 | $8,750 | 48.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 78 | 80 | $8,824 | $6,031 | 68.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 42 | 61 | $8,662 | $5,336 | 61.6% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 40 | 54 | $10,800 | $5,311 | 49.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 27 | 133 | $9,709 | $5,153 | 53.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 22 | $9,548 | $4,697 | 49.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 25 | 37 | $7,733 | $4,658 | 60.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 48 | 51 | $10,455 | $4,537 | 43.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 29 | 30 | $5,700 | $2,884 | 50.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 67 | $5,025 | $2,731 | 54.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 81 | $3,645 | $2,534 | 69.5% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 13 | 15 | $4,185 | $2,061 | 49.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 39 | 48 | $3,984 | $1,931 | 48.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $3,840 | $1,847 | 48.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 24 | 37 | $2,331 | $1,227 | 52.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 13 | 23 | $1,357 | $727.35 | 53.6% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 12 | 12 | $1,572 | $714.12 | 45.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 62 | $1,364 | $673.96 | 49.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 71 | 72 | $1,656 | $626.29 | 37.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 15 | $1,065 | $582.00 | 54.6% |
About Dr. Mukesh Mehta, M.D
Dr. Mukesh Mehta, M.D is a Internal Medicine healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558361188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mukesh Mehta, M.D has received a total of $18,042 in payments from pharmaceutical and medical device companies, with $2,212 received in 2024. These payments were reported across 1,011 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($17,885).
As a Medicare-enrolled provider, Mehta has provided services to 6,627 Medicare beneficiaries, totaling 9,972 services with total Medicare billing of $631,830. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Katy, TX
- Active Since 07/26/2005
- Last Updated 12/17/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558361188
Products in Payments
- FARXIGA (Drug) $2,700
- JARDIANCE (Drug) $1,222
- Ozempic (Drug) $1,098
- XARELTO (Drug) $748.07
- ENTRESTO (Drug) $543.31
- Kerendia (Drug) $484.48
- BREZTRI (Drug) $477.38
- XIFAXAN (Drug) $441.29
- TRELEGY ELLIPTA (Drug) $410.82
- Saxenda (Drug) $409.83
- EVENITY (Biological) $359.23
- RYBELSUS (Drug) $344.34
- NURTEC ODT (Drug) $333.76
- MYRBETRIQ (Drug) $324.31
- TOUJEO (Drug) $323.69
- Rybelsus (Drug) $259.03
- Wegovy (Drug) $249.15
- BYDUREON (Drug) $246.78
- Otezla (Drug) $233.49
- JANUVIA (Drug) $226.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Katy
Dharmendra Verma, M.d, M.D
Internal Medicine — Payments: $43,959
Internal Medicine $43,959
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,985
Internal Medicine $20,985
Dr. Moo Chung, M.d, M.D
Internal Medicine — Payments: $17,384
Internal Medicine $17,384
Roger Campana, Md, MD
Internal Medicine — Payments: $17,323
Internal Medicine $17,323
Mr. Barry Troyan, Md, MD
Internal Medicine — Payments: $16,038
Internal Medicine $16,038
Viswanath Kalapatapu, M.d, M.D
Internal Medicine — Payments: $14,406
Internal Medicine $14,406